|
|
|
|
|
|
|
Products: Lead Drug: We have developed a prototype GlyTag fusion protein called “GlyB4” for treating breast cancer. This drug is currently completing pre-clinical testing and looks quite promising as a new, targeted treatment for breast cancers. |
|
|
© GlyTag
LLC
|
|
